Published on
October 13, 2017
- 13:27 GMT
Resverlogix Announces $87 Million Private Placement with Shenzhen Hepalink
CALGARY, Alberta, Oct. 13, 2017 (GLOBE NEWSWIRE) -- Resverlogix Corp. ("Resverlogix" or the "Company") (TSX:RVX) announced a private placement of 60,416,667 equity units to Shenzhen Hepalink Pharmaceutical Co. Ltd. (“Hepalink”) at a …
Distribution channels:
Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry
...
